Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001179110-20-009170

EVP/Chief Scientific Officer sold 10,000 shares at $35.29 ($352,900)

  • EVP/Chief Scientific Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Albright Charles EVP/Chief Scientific Officer 2020-08-17 Option exercise +10,000 $16.51 $165,100 38,135 D: show line 1 in the form
Albright Charles EVP/Chief Scientific Officer 2020-08-17 Sale −10,000 $35.29 $352,900 28,135 D: show line 2 in the form
Open-market sales · 10,000 sh · avg $35.29 · $352,900

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Albright Charles EVP/Chief Scientific Officer 2020-08-17 Option exercise · Stock Option (right to buy) −10,000 185,000 D: show line 3 in the form
Loading xslF345X03/edgar.xml…